HolderBook

Altitude Crest Partners Inc.

Reported holdings as of Q1 2024, from 2 quarterly filings.

This filer last reported in Q1 2024; the most recent quarter on file across all filers is Q2 2026. Firms that restructure stop filing under one CIK and start under another, so a successor entity may hold these positions now under a similar name.

CIK
1986035
Reported value
$233.6M
Positions
30
Top 10 weight
69.3%
Filed
2024-05-14
Days after quarter end
44

Holdings

SecurityTickerValue SharesWeightWeight change Held Change
LEGEND BIOTECH CORPLEGN$36.6M652,73215.67%-6.14pp2q+20.5%+$6.2M
DANAHER CORP DELDHR$27.1M108,70011.62%-7.20pp2q-10.6%-$3.2M
BRIDGEBIO PHARMA INCBBIO$18.9M612,0608.10%-12.28pp2q-18.9%-$4.4M
STEVANATO GROUP S P ASTVN$17.7M550,0007.56%-newNEW
APELLIS PHARMACEUTICALS INCAPLS$16.9M287,2777.23%+1.13pp2q+88.7%+$7.9M
THERMO FISHER SCIENTIFIC INCTMO$10.7M18,4004.58%-newNEW
ARRIVENT BIOPHARMA INCAVBP$9.9M555,5554.25%-newNEW
STRUCTURE THERAPEUTICS INCGPCR$8.8M205,1663.76%-newNEW
KINIKSA PHARMACEUTICALS LTDKNSA$7.9M400,4413.38%-1.97pp2q-12.2%-$1.1M
JANUX THERAPEUTICS INCJANX$7.3M193,3003.12%-newNEW
ELI LILLY & COLLY$7.2M9,2003.06%-newNEW
BIOHAVEN LTDBHVN$6.5M118,3802.77%-newNEW
IMMUNOME INCIMNM$6.5M262,2842.77%-newNEW
SPRINGWORKS THERAPEUTICS INCSWTX$6.3M128,8422.71%-newNEW
GERON CORPGERN$5.1M1,531,4002.16%-newNEW
ICON PUB LTD COICLR$5.0M14,8002.13%-newNEW
MERUS N VMRUS$4.9M109,8372.12%-newNEW
ROIVANT SCIENCES LTDROIV$4.8M454,7662.05%-4.02pp2q-43.7%-$3.7M
DENALI THERAPEUTICS INCDNLI$4.3M209,6131.84%-newNEW
CORBUS PHARMACEUTICALS HLDGSCRBP$4.1M103,7031.74%-newNEW
AGIOS PHARMACEUTICALS INCAGIO$3.3M113,1001.42%-newNEW
DAY ONE BIOPHARMACEUTICALS IDAWN$3.2M195,4971.38%-newNEW
ALIGOS THERAPEUTICS INCALGS$2.8M2,844,6811.19%-0.07pp2qHELD
ENGENE HOLDINGS INCENGN$2.0M120,2890.87%-newNEW
APPLIED THERAPEUTICS INCAPLT$1.8M259,7000.76%-newNEW
ZYMEWORKS INCZYME$1.5M145,5810.66%-newNEW
METAGENOMI THERAPEUTICS INCMGX$1.4M133,3330.60%-newNEW
TOURMALINE BIO INCTRML$1.1M47,4000.46%-newNEW
ALNYLAM PHARMACEUTICALS INCALNY$29.9K2000.01%-newNEW
SURROZEN INCSRZNW$12.5K384,5730.01%flat2qHELD

By sector

Industry comes from the SIC code on each company's own SEC filings, which is self-reported and sometimes out of date. Derivative exposure is counted with the shares. Securities the SEC assigns no industry - funds, trusts, foreign issues - are shown as not classified rather than dropped.

Biotech & Pharma 61.6%Instruments & Controls 16.2%Medical Devices 7.6%Not classified 14.7%
 
SectorValueShare
Biotech & Pharma$143.8M61.6%
Instruments & Controls$37.8M16.2%
Medical Devices$17.7M7.6%
Not classified$34.3M14.7%

Quarter by quarter

QuarterValuePositions NewAddedTrimmed ExitedTop 10 Days to file
Q1 2024$233.6M302224469.3%44
Q4 2023$149.4M12000099.6%45

Rows marked UNVERIFIED ID, PLACEHOLDER ID, TICKER AS ID or NON-CUSIP ID carry an identifier that is not a valid CUSIP. They are shown because the filer reported that money, but treat the security named with caution - hover the chip for what is wrong with it, and see the methodology.

Held counts consecutive filings in which this manager reported the position, and can reach further back than the quarters listed above: the tabs begin at Q4 2018 because earlier coverage is too sparse to describe a market, but tenure is counted over every filing we hold, some reaching to 2007. A position sold and later rebought starts again from one.

Weight change is the shift in this position's share of the whole book, in percentage points. It is the more useful column: when money flows into or out of a broad fund, almost every holding is bought or sold at once, so added and trimmed largely track flows. A weight that rose while the book shrank is a decision. Both compare with the previous quarter this filer reported, not the previous calendar quarter.